Adamis Pharmaceuticals Corp.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 2.30%54.260.9%$2601.90m
JNJJohnson & Johnson 1.43%159.340.7%$1311.17m
MRKMerck & Co., Inc. -0.77%73.320.7%$1166.64m
BMYBristol-Myers Squibb Co. 1.61%56.301.0%$773.14m
LLYEli Lilly & Co. -0.93%245.571.1%$726.06m
ABBVAbbVie, Inc. 1.72%118.881.9%$593.69m
AZNAstraZeneca Plc -1.02%54.231.0%$295.20m
NVSNovartis AG 0.06%80.000.2%$175.98m
GSKGlaxoSmithKline Plc -0.53%41.250.2%$162.67m
DRNADicerna Pharmaceuticals, Inc. 0.34%38.250.3%$148.96m
VTRSViatris, Inc. 0.00%12.200.0%$142.65m
RPRXRoyalty Pharma Plc -3.16%37.650.1%$112.47m
BFRIBiofrontera, Inc. -18.67%4.270.0%$107.17m
RGENRepligen Corp. -2.21%262.886.7%$105.50m
NVONovo Nordisk A/S 0.45%107.120.1%$85.21m

Company Profile

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company provides products in various therapeutic areas, including allergy, respiratory, opioid overdose, and erectile dysfunction markets. It offers the SYMJEPI Injection for the emergency treatment of allergic reactions. The company was founded in June 2006 and is headquartered in San Diego, CA.